Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells

Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells

US Patent 11884716 · Granted Jan 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Compositions and methods for targeting γδ T cells with chimeric antigen receptor2025
Methods and composition for gene delivery using an engineered viral particle2024
Method of redirecting t cells to treat HIV infection2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Compositions and methods of muscle specific kinase chimeric autoantibody recepto2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Methods and compositions for gene editing in hematopoietic stem cells2023
Biomarkers predictive of cytokine release syndrome2023
Methods and composition for gene delivery using an engineered viral particle2023
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2023